CanPursue

Research

  • Search
  • Opportunities
  • Buyers
  • Suppliers
  • Contracts
  • Awards

Intelligence

  • OverviewAccount required
  • WatchlistsAccount required
  • PipelineAccount required
  • IntelligenceAccount required
Create free account

Sign in

⌘K
ENFR
Amend 012 - PERTUSSIS VACCINES - GlaxoSmithKline Inc. | Government contract · CanPursue
Contracts

Amend 012 - PERTUSSIS VACCINES - GlaxoSmithKline Inc.

Department of Public Works and Government Services (PSPC)GlaxoSmithKline Inc.E60PH-21PERT/002/PH
Find on CanadaBuysWatch
Total contract value
$69.7M
Original award value
$206.9K
Start
Jan 5, 2021
End
Mar 31, 2026

Timeline

Official
  • AwardedJan 5, 2021. Original award value: $206.9K
  • Amendment 10Dec 17, 2025. Value change: $69.7M
  • Observed expiryMar 31, 2026
Contract number
E60PH-21PERT/002/PH
Awarded
Jan 5, 2021
Instrument
—
Status
—
Amendments
1 amendment
Source
CanadaBuys (Find on CanadaBuys)
E60PH-21PERT/002/PH:10
Related procurement
No linked procurement observed.